Effect of combination therapy with UFT plus cisplatin (UFTP) on the survival of mice in the experimental model for wide-spread metastasis in the peritoneal cavity of gastrointestinal cancer using colon 26 PMF-15 cells

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 2217-2220

  Kurihara, Minoru ^a   Uchida, Junji ^b   Fujioka, Akio ^b   Kato, Toshiyuki ^b   Ohshimo, Hideyuki ^b   Abe, Masaaki ^b   Takeda, Setsuo ^b   Fukushima, Masakazu ^b  

^a SHOWA UNIVERSITY   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

CDDP; Effect on survival; Experimental model for metastasis in the peritoneal cavity of gastrointestinal cancer; UFT; UFTP

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; TEGAFUR; URACIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CARCINOMA CELL; COLON CARCINOMA; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; EXPERIMENTAL MODEL; EXPERIMENTAL NEOPLASM; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PERITONEAL CAVITY; PERITONEUM METASTASIS; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BODY WEIGHT; CELL LINE; CISPLATIN; COLONIC NEOPLASMS; DRUG COMBINATIONS; GASTROINTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED STRAINS; PERITONEAL NEOPLASMS; SURVIVAL RATE; TEGAFUR; URACIL;

EID: 0030861259     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ohmori Y, Maruyama K, Kikuchi S et al: Stomach Cancer in Japan, Stomach Cancer Study Group ed. Kanahara Tokyo: 1996.
2. Moynihan T, Hansen R, Anderson T et al: Continuous 5-fluorouracil infusion in advanced gastric carcinoma. Am J Clin Oncol 11: 461-464, 1988.
3. Barbounis VP, Kalofonos HP, Munro AJ et al: Treatment of colorectal cancer and other malignancies with continuous infusion of 5-fluorouracil. Anticancer Res 9: 33-40, 1989.
4. Lokich JJ, Ahlgren JD, Philips JA et al: A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma, A mild-atlantic oncology program study. J Clin Oncol 7: 425-432, 1989.
5. Hansen R, Quebbeman E, Beatty P et al: Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat 10: 145-149, 1987.
6. Namatame K, Sasaki E, Ko Y et al: A double-blind comparison of FUra plasma concentration by oral (UFT) vs continuous intravenous infusion (5FU). Jpn J Cancer Chemother 20: 2417-2419, 1993.
7. Yoshida T, Araki E, Iigo M et al: Clinical significance of monitoring serum levels of 5-fluorouracil by infusion in patients with advanced colonic cancer. Cancer Chem Pharma 26: 352-354, 1990.
8. Kurihara M, Izumi T, Yoshida S et al: A cooperative randomized study on Tegafur plus Mitomycin C versus Combined Tegafur and uracil plus Mitomycin C in the treatment of advanced gastric cancer. Jpn J Cancer Res 82: 613-620, 1991.
9. Wils J, Bleiberg H, Dalesio O et al: An EORTC gastrointestinal group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer. J Clin Oncol 4: 1799-1803, 1986.
10. Rougier PH, Ducreux M, Mahjoubi M et al: Efficacy of combined 5-fluorouracil and Cisplatinum in advanced gastric carcinomas. A phase II trial with prognostic factor analysis. Eur J Cancer 30: 1263-1269, 1994.
11. Lacave AJ, Baron FJ, Anton LM et al: Combination chemotherapy with cisplatin and 5-fluorouracil-5day infusion in the therapy of advanced gastric cancer: A phase II trial. Annals of Oncology 2: 761-754, 1991.
12. Ohtsu A, Shimada Y, Yoshida S et al: Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer, Report from the Japan Clinical Oncology Group (JCOG). Eur J Cancer 30: 2091-2093, 1994.
13. Sato A, Hasegawa K, Kurihara M et al: Combination chemotherapy with tegafur-uracil (UFT) and cisplatin (CDDP) for advanced gstric cancer. Jpn J Cancer Chemother 22: 1355-1362, 1995.
14. Shinoda M, Morise K, Kusugami K, Iwase H et al: Combination chemotherapy with FP versus FEP in patients with advanced gastric cancer. Jpn J Cancer Chemother 22: 515-520, 1995.
15. Scanlon KJ, Newman EM, Priest DG: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83: 8923-8925, 1986.
16. Ohie S, Okabe H, Takeda S et al: Analysis of the mechanism of increased antitumor activity of UFT after combined treatment with CDDP. Jpn J Cancer Chemother 17: 1321-1326, 1990.
17. Yamada Y, Saito H, Takeda S et al: Expeimental study of the effect of combined treatment of UFT with CDDP on human solid tumor-xenografts in nude mice. Jpn J Cancer Chemother 17: 1327-1331, 1990.
18. Uchida J, Satake H, Saito H et al: Experimental evaluation of combination chemotherapy with UFT and cisplatin for the lung cancer. Jpn J Cancer Chemother 21: 1001-1008, 1994.
19. Namatame K, Sasaki E, Ko Y et al: A double-blind comparison of FUra plasma concentration by oral (UFT) continuous intravenous infusion (5FU). Jpn J Cancer Chemother 20: 2417-2419, 1993.